Cutaneous vasomotor effects of neuropeptide Y

Neuropeptides

Volumn 29, Issue 5, 1995, Pages 263-271

  Hashim, M A ^a   Tadepalli, A S ^a  

^a Burroughs Wellcome Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEXAMETHONIUM; NEUROPEPTIDE Y DERIVATIVE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR AGONIST; NORADRENALIN; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN; SKIN BLOOD FLOW; VASODILATATION;

ADRENERGIC ALPHA-AGONISTS; ANIMAL; DENERVATION; GANGLIONIC BLOCKERS; HEXAMETHONIUM; KINETICS; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; NEUROPEPTIDE Y; NOREPINEPHRINE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; VASODILATION;

ANIMALIA;

EID: 0028861114     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/0143-4179(95)90035-7     Document Type: Article

References (31)

1. Neuropeptide Y — a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide
2. Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of electrically stimulated mouse vas deferens
3. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function
4. Origin and actions of neuropeptide Y in the cardiovascular system
5. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers
6. The effects of neuropeptide Y on myocardial contractility and coronary blood flow
7. Ultrastructural localization of neuropeptide Y-immunoreactivity in the axonal reticulum elements, accumulating anterogradely in transected rat sciatic nerve
8. 2 receptors; evidence from benextramine protection studies
9. Heterogeneity of prejunctional neuropeptide Y receptors inhibiting noradrenaline overflow in the portal vein of freely moving rats
10. 3H]-noradrenaline and the contractile response evoked by field stimulation in the rat vas deferens
11. Pre- and postjunctional effects of NPY on sympathetic control of rat femoral artery
12. Actions of calcium channel antagonists on pre- and postjunctional effects of neuropeptide Y on human peripheral blood vessels in vitro
13. The role of alpha adrenoceptor subtypes in sympathetic control of the acral-cutaneous microcirculation
14. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals
15. Characterization of receptor types for neuropeptide Y and related peptides
16. Evidence for two neuropeptide Y receptors mediating vasoconstriction
17. Neuropeptide Y (NPY): Enhancement of blood pressure increase upon alpha-adrenoceptor activation and direct pressor effects in pithed rats
18. Actions of neuropeptide Y on innervated and denervated rat tail arteries
19. Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem
20. Comparison of locations and peptide content of postganglionic neurons innervating veins and arteries of the rat hindlimb
21. Mechanisms of central endothelin-induced hypotension
22. 2 prejunctional receptor
23. Characterization of vascular neuropeptide Y receptors
24. Possible location and function of neuropeptide Y receptor subtypes in the rat mesenteric arterial bed
25. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney
26. Different neuropeptide Y receptor subtypes in rat and rabbit vas deferens
27. Effects of neuropeptide Y on the cardiovascular system
28. Selective constriction of small cutaneous arteries by NPY matches distribution of NPY in sympathetic axons
29. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate adrenergic responses in rats
30. [Leu31, Pro34] NPY, a selective functional postjunctional agonist at neuropeptide-Y receptors in anaesthetised rats
31. Age-dependent hyperresponsiveness of spontaneously hypertensive rats to the pressor effects of intravenous neuropeptide Y (NPY): Role of mode of peptide administration and plasma NPY-like immunoreactivity